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Abstract
Background: Genome-wide association studies (GWAS) have become a major strategy for genetic dissection of
human complex diseases. Analysing multiple phenotypes jointly may improve both our ability to detect genetic
variants with multiple effects and our understanding of their common features. Allelic associations for multiple
biochemical traits (serum alanine aminotransferase, aspartate aminotransferase, butrylycholinesterase (BCHE), C-
reactive protein (CRP), ferritin, gamma glutamyltransferase (GGT), glucose, high-density lipoprotein cholesterol
(HDL), insulin, low-density lipoprotein cholesterol (LDL), triglycerides and uric acid), and body-mass index, were
examined.
Methods: We aimed to identify common genetic variants affecting more than one of these traits using genome-
wide association analysis in 2548 adolescents and 9145 adults from 4986 Australian twin families. Multivariate and
univariate associations were performed.
Results: Multivariate analyses identified eight loci, and univariate association analyses confirmed two loci
influencing more than one trait at p < 5 × 10
-8. These are located on chromosome 8 (LPL gene affecting HDL and
triglycerides) and chromosome 19 (TOMM40/APOE-C1-C2-C4 gene cluster affecting LDL and CRP). A locus on
chromosome 12 (OASL gene) showed effects on GGT, LDL and CRP. The loci on chromosomes 12 and 19
unexpectedly affected LDL cholesterol and CRP in opposite directions.
Conclusions: We identified three possible loci that may affect multiple traits and validated 17 previously-reported
loci. Our study demonstrated the usefulness of examining multiple phenotypes jointly and highlights an
anomalous effect on CRP, which is increasingly recognised as a marker of cardiovascular risk as well as of
inflammation.
Background
Genome-wide association studies (GWAS) have become
a major strategy for genetic dissection of human com-
plex diseases. There is substantial overlap, both pheno-
typically and in allelic associations, between biomarkers
and/or risk factors and between related diseases, and it
is becoming important to understand the ways in which
polymorphisms affect multiple phenotypes. Many phe-
notypes may be available from a single study population
but current GWAS approaches usually examine them
separately within a univariate framework. This strategy
ignores potential genetic correlation between different
traits.
From the perspective of maximising power for a given
size of dataset, it has been shown that joint analyses of
correlated traits in linkage analysis have substantially
improved power in localizing genes [1-4]. Similarly, mul-
tivariate approaches in association studies can theoreti-
cally improve the ability to detect genetic variants
whose effects are too small to be detected in univariate
tests [4]. Multivariate association tests have been pro-
posed for unrelated samples [5] and for family data [6].
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tionally intensive, especially at the genome-wide level.
The approach proposed by Ferreira and Purcell has
been shown to be powerful when traits have moderate
to high correlation and efficient when applied to sam-
ples of unrelated individuals [7].
Genetically complex (multifactorial) diseases such as
cardiovascular disease and type 2 diabetes often have com-
mon risk factors. A number of biochemical markers are
known to be associated with obesity, pre-diabetic states, or
risk of cardiovascular disease. Lipid traits such as triglycer-
ides, and the low-density lipoprotein (LDL) and high-den-
sity lipoprotein (HDL) components of cholesterol, are
well-known risk factors for cardiovascular disease. Other
biochemical markers such as C-reactive protein (CRP) [8],
the enzymes used as liver function tests (gammaglutamyl
transferase, GGT [9-11], alanine aminotransferase, ALT;
and aspartate aminotransferase, AST), butyrylycholinester-
a s e( B C H E )[ 1 2 , 1 3 ] ) ,s e r u mf e r r i t i n[ 1 4 ]a n du r i ca c i d
[15,16] have also been shown to be associated with the
risk of cardiovascular disease, hypertension, obesity, insu-
lin resistance or metabolic syndrome. These biochemical
markers are correlated so we may gain power, insight or
both from a multivariate approach. For example, serum
GGT is significantly correlated with total or LDL choles-
terol, HDL (inversely) and particularly with triglycerides
[17,18]. Also, GGT is significantly correlated with other
liver enzymes AST and ALT [17,19]. Serum triglyceride is
correlated with the liver enzymes [17] and uric acid and
also associated with cardiovascular risk.
The importance of genetic variation has been shown
previously through univariate analyses of serum lipids
[20], uric acid [21-23], GGT [24], ALT [24] and AST
[17,24], BCHE [25], ferritin [26] and for CRP [27,28].
Nevertheless, little is known about common genetic
influences on these variables and joint analysis may
reveal whether the same gene influences multiple traits.
The aim of our study is to identify genes and regions
associated with multiple biochemical traits related to car-
diovascular risk, type 2 diabetes or metabolic syndrome.
We used a recently described multivariate association
test [7] to perform genome-wide association analysis.
This approach was used initially to screen for multivari-
ate trait-SNP association using a subset of unrelated indi-
viduals. To confirm findings from the multivariate test,
univariate association tests were conducted making use
of the full dataset by including all family members.
Methods
Subjects
Biochemical traits were measured in serum samples
from twins and their families, and genome-wide SNP
markers were genotyped. The study participants
comprise:
(1) Adolescent twins and their non-twin siblings living
in south-east Queensland (Australia) who had partici-
pated in the Brisbane Longitudinal Twin study [29-32].
Full details are described in Middelberg et al. [33]. A
total of 2548 participants (1317 females and 1231 males;
mean age of 14.8 years) were genotyped.
(2) Adult twins consisting of twins and their family
members who participated in studies of: (i) alcohol and
nicotine dependence and metabolic risk for alcoholic
liver disease [34]; (ii) anxiety and depression [35]; and
(iii) endometriosis [36]. A total of 9145 individuals
(5703 females and 3442 males; mean age of 46.2 years)
were genotyped.
Combining these studies, 20,230 individuals had bio-
chemical measurements and 11,683 (from 4986 families)
had both genotype and phenotype data. Out of the
11,683, there are only 1483 (from 1015 families) who
had data for all the 13 traits. Where multiple measure-
ments of the same trait in an individual were available,
the average of the values was used.
For each of these studies, participants (and, for sub-
jects aged < 18 years, their parents) gave informed con-
sent to the questionnaire, interview, and blood
collection, and all studiesw e r ea p p r o v e db yt h eQ I M R
Human Research Ethics Committee.
Laboratory measurements
Serum was separated from the blood samples and stored
at -70°C until analyzed. Serum cholesterol, HDL choles-
terol, triglycerides, BCHE, glucose, uric acid, ferritin,
CRP, AST, ALT and GGT were measured using Roche
methods on a Roche 917 or Modular P analyzer (Roche
Diagnostics, Basel, Switzerland). LDL cholesterol was
calculated using the Friedewald equation. Insulin was
measured on an Abbott Architect. BMI was calculated
from measured or self-reported weight and height for
the adults and from measured weight and height for the
adolescents.
Genotyping
DNA was extracted from blood samples using standard
methods and genotyped with Illumina 610K, 317K or
370K chips at CIDR or deCODE Genetics. Data cleaning
for SNP genotypes included checking the expected rela-
tionships between individual family members and resol-
ving Mendelian errors [37]. Imputed genotypes for non-
typed HapMap SNPs were generated using MACH1.0
(http://www.sph.umich.edu/csg/abecasis/mach/index.
html) [38-40] program. Any imputed SNP which had r
2
≥ 0.3 was included in the genotype data.
Statistical Analysis
Distributions of all biochemical variables were examined.
Serum AST, ALT and GGT, CRP, triglycerides and BMI
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were more than five standard deviations from the mean
of that trait were excluded. Results for glucose and insu-
lin in adults were adjusted for fasting time based on the
reported time of last meal and time of blood collection.
Prior to genetic association analysis, the variables were
also adjusted for the effects of age, squared age (age
2),
sex, sex × age and sex × age
2. Standardized residuals
were obtained and used in the association analysis. All
data pre-processing and descriptive analyses were done
using STATA version 7.0 [41] and SPSS version 17.0.2
(Mar 11, 2009). Multivariate association analysis was
performed using the PLINK (v1.07) implementation of
the multivariate test described by Ferreira and Purcell
[7]. This test is computationally too intensive when
applied to family data to be efficient for genome-wide
analysis. Therefore the analysis was performed in two
stages. First, we selected one individual per family (using
the person with data for the greatest number of pheno-
types) from each of the 4986 families and applied the
multivariate test as a screening tool. Next, for each
locus with a multivariate p-value of less than 5 × 10
-8,
we identified the traits that showed evidence for associa-
tion with that locus (that is, with a canonical correlation
weight > |0.2|) and confirmed that specific trait-SNP
association with a univariate association test using all
relatives for each family. The univariate association test
was performed using “fastassoc“ in MERLIN 1.1.2 [42]
which takes the average of two results in MZ twin pairs.
Results
General Characteristics
Means and standard deviations of all the traits for males
and females in adolescent and adult genotyped cohorts
are listed in Additional file 1, Table S1. Generally, the
means of the biochemical traits are lower in the adoles-
cents than the adults, as expected. Phenotypic correla-
tions between each pair of age-corrected traits
separately for males and females in the combined sam-
p l ea r es h o w ni nA d d i t i o n a lf i l e1 ,T a b l eS 2 .T h es t r o n -
gest correlations (r > 0.5) observed in males were
between glucose and insulin (0.53), between AST and
ALT (0.66) and between GGT and ALT (0.57). In the
females, the strongest correlations observed were
between glucose and insulin (0.59), between BCHE and
glucose (-0.59), between BCHE and CRP (-0.53) and
b e t w e e nA S Ta n dA L T( 0 . 6 3 ) .G i v e nt h a tm o s to ft h e
other pair-wise correlations (Additional file 1, Table S2)
are low to moderate (r < 0.3), the multivariate approach
is expected to provide comparable or slightly improved
power to detect pleiotropic loci when compared to uni-
variate analysis followed by correction for the number
of traits tested [7].
Genome-wide association analyses
T h em u l t i v a r i a t ea n a l y s i si dentified a total of 766 SNPs
in 11 independent (r
2 < 0.1) loci associated with bio-
chemical traits with a p-value of less than 5 × 10
-8
(Table 1 and Figure 1). Of these, there are eight loci
potentially associated with more than one trait (Table
1). Three loci (on chromosomes 8, 12 and 19) showed
strong or close to genome-wide significant evidence of
associations with more than one trait in the all-subject
univariate analyses.
The most strongly associated SNP at the chromosome
8p21.3 locus was rs17091905 (multivariate p = 2.8 × 10
-
13). HDL, CRP, triglycerides and BCHE had trait load-
ings of greater than |0.2|. To confirm the multivariate
result, we individually tested each of these traits using a
univariate test in the full sample of 11,683 individuals.
The univariate tests confirmed the association with
HDL (p = 5.7 × 10
-12) and triglycerides (p = 5.1 × 10
-15)
but not at genome-wide significance for CRP (p =
0.008) and non-significant (p = 0.069) for BCHE. This
variant is in strong or partial LD with previously-
reported variants for HDL or triglycerides [43-45]
(Additional file 1, Table S3).
The second variant rs3213545 (multivariate p-value =
3.9 × 10
-14) which is located on chromosome 12q24.2
(OASL) was confirmed to be significantly associated
w i t hG G T( p=3 . 6×1 0
-15)[ 4 6 ]a n da l s os h o w e dm o d -
erately strong significance for LDL (p = 2.9 × 10
-5)a n d
CRP (p = 8.8 × 10
-5) (Table 1).
The third variant was rs2075650 (multivariate p-value
=5 . 7×1 0
-10) located on chromosome 19q13.32
(TOMM40/APOE-C1-C2-C4 gene cluster) where HDL,
LDL, CRP and triglycerides had trait loadings of greater
than |0.2|. Significant univariate associations were
observed for LDL (p = 1.6 × 10
-14)a n dC R P( p=4 . 2×
10
-8) and close to genome-wide significant univariate
associations were seen for HDL (p = 8.1 × 10
-8) and tri-
glycerides (p = 9.6 × 10
-7)( T a b l e1a n dF i g u r e2 ) .T h i s
SNP has previously been reported to be associated with
LDL [43], LDL buoyancy [47] and CRP [48], and there
is an association between LDL (or TG or HDL) and
rs4420638 which is in partial LD (r
2 =0 . 4 )w i t ht h i s
SNP (Additional file 1, Table S3).
To determine whether there are any further unre-
ported genes/regions to be detected by multivariate ana-
lysis, a lower p-value threshold of multivariate p < 9 ×
10
-5 was used. No new loci were found but a further six
previously reported loci were replicated as listed in
Additional file 1, Table S4.
The Q-Q plot from multivariate analysis was also
examined closely to determine whether there are any
excess association signals detected by multivariate analy-
sis which have not already been detected by univariate
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(genes) in univariate analyses were removed (Figure 3)
from the plot. The Q-Q plot with excluded SNPs
showed that there is no excess of significant p-values
hence indicating there are additional loci that have not
already been detected by univariate analysis.
Examination of the directions of the allelic effects on
the different phenotypes showed unexpected results. At
Table 1 Summary of SNP associations (based on multivariate p-value of < 5 × 10
-8)
Chr BP SNP Closest
Gene
Minor/Major
Allele
MAF N multivariate P-
value
Associated
Trait(s)
Univariate analysis
N b* SE univariate
p
1 109,619,361 rs660240 CELSR2 T/C 0.215 4883 7.0 × 10
-9 LDL 11247 -0.170 0.017 2.1 × 10
-22
HDL 11545 0.047 0.017 0.007
INS 2559 0.035 0.040 0.390
2 21,097,505 rs10199768 APOB T/G 0.470 4872 2.3 × 10
-8 LDL 11205 0.110 0.014 7.7 × 10
-15
CRP 8878 -0.015 0.015 0.330
FERR 11285 0.032 0.014 0.020
3 166,973,974 rs1803274 BCHE T/C 0.206 4883 2.4 × 10
-42 BCHE 9171 -0.365 0.018 5.9 × 10
-92
4 9,665,474 rs7671266 WDR1 T/C 0.208 4883 1.8 × 10
-42 UA 11346 -0.305 0.017 9.3 × 10
-71
4 9,940,392 rs4698036 Intergenic G/T 0.218 4884 8.5 × 10
-31 UA 11354 -0.257 0.017 2.3 × 10
-52
8 19,894,037 rs17091905 LPL A/G 0.124 4884 2.8 × 10
-13 HDL 11546 0.150 0.022 5.7 × 10
-12
TRIG 11576 -0.174 0.022 5.1 × 10
-15
CRP 8918 0.062 0.024 0.008
BCHE 9168 -0.042 0.032 0.069
10 17,931,828 rs2437258 MRC1 T/C 0.226 4884 7.1 × 10
-9 AST 11516 0.102 0.016 3.0 × 10
-10
FERR 11332 0.015 0.016 0.350
TRIG 11579 0.027 0.017 0.116
ALT 11518 -0.012 0.017 0.460
12 119,955,720 rs3213545 OASL A/G 0.295 4876 3.9 × 10
-14 GGT 11493 -0.121 0.015 3.6 × 10
-15
LDL 11228 0.066 0.016 2.9 × 10
-5
CRP 8903 -0.066 0.017 8.8 × 10
-5
TRIG 11556 0.021 0.016 0.180
15 56,465,804 rs10468017 LIPC T/C 0.326 4864 2.8 × 10
-11 HDL 11497 0.104 0.015 2.8 × 10
-12
TRIG 11527 0.048 0.015 0.002
16 55,545,545 rs173539 CETP T/C 0.324 4884 1.7 × 10
-40 HDL 11549 0.255 0.015 3.3 × 10
-65
LDL 11251 -0.050 0.015 0.001
19 50,087,459 rs2075650 TOMM40 G/A 0.152 4884 5.7 × 10
-10 LDL 11248 0.153 0.020 1.6 × 10
-14
CRP 8918 -0.116 0.021 4.2 × 10
-8
HDL 11546 -0.105 0.020 8.1 × 10
-8
TRIG 11576 0.098 0.020 9.6 × 10
-7
SNPs highlighted in bold indicate the polymorphisms that are significantly associated with more than one trait; traits highlighted in bold are those which
achieved significance in the univariate analysis.
* b represents 1 unit change in e.g. LDL (mmol/l) per copy increment in the minor allele; TRIG indicates triglycerides.
Figure 1 Manhattan plots for multivariate QTL analysis in unrelated-subject data (N = 4986) for the 13 traits. Genomic position is on
the x-axis and the -log10 of the association p-value is on the y-axis. Points with p-value of 5 × 10
-8 are shown in red.
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rs17091905 increased HDL-C and decreased triglycer-
ides, but the direction of the nominally significant effect
on CRP was to increase it. At the chromosome 12 locus
the minor allele A at rs3213545 tended to increase
LDL-C but it significantly decreased GGT and tended to
decrease CRP. Similarly at the chromosome 19 locus,
the effect of the minor allele (G for rs2075650) was to
increase LDL-C and triglycerides and to decrease HDL-
C, consistent with an increase in cardiovascular risk, but
to decrease CRP, again suggesting opposite allelic effects
on the markers of different aspects of cardiovascular
risk.
Discussion
We have applied a multivariate approach to identify var-
iants associated with more than one trait, initially using
4986 unrelated individuals across 13 biochemical traits.
Univariate testing of the significant or near-significant
loci, on the full sample of 11,683 individuals, was then
Figure 2 Radar chart of polymorphisms on chromosome8 (a), chromosome 12 (b) and chromosome 19 (c). Each dot on the plot
represents the standardized beta (1-unit change per copy increment of the minor allele) of each trait from univariate testing.
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i nt h eu s e f u l n e s so fm u l t i v a r i a t ea n a l y s i sa sas u b s t i t u t e
for the more laborious and potentially less powerful
approach of conducting multiple univariate analyses and
comparing the results, and secondly in the details of the
loci which are found to have effects on multiple vari-
ables in our data.
Testing one individual per family identified three
known loci that were significantly or near-significantly
associated with more than one trait, and replicated 11
loci in previously published genes that that passed a
genome-wide threshold of 5 × 10
-8 for single variables
(Table 1). When a lower genome-wide threshold (p < 9
×1 0
-5) was used, a further six published loci were also
identified (Additional file 1, Table S4). The three loci in
previous publications using univariate association analy-
sis (highlighted in Table 1) had evidence of significant
or close to significant associations with more than one
trait in our data, hence indicating benefits of detecting
pleiotropic loci in multivariate analysis.
We have identified polymorphisms showing strong
evidence of allelic associations with HDL and triglycer-
ides on chromosome 8 (LPL gene MIM 609708); with
GGT and possibly LDL and CRP on chromosome 12
(OASL gene MIM 603281); and with HDL and LDL and
possibly CRP and triglycerides on chromosome 19
(TOMM40 (MIM 608061) /APOE (MIM 107741)-C1
(MIM 107710)-C2 (MIM 608083)-C4 (MIM 600745)
gene cluster). Each gene has been previously recognised
in genome-wide association studies concentrating on a
few of these variables [49]. The function of these genes
is reasonably well-established. LPL p l a y sak e yr o l ei n
lipid metabolism and is responsible for hydrolysis of tri-
glyceride molecules present in circulating lipoprotein.
APOE and APOC genes also play a key role in lipid
metabolism and cholesterol transport by helping to sta-
bilise and solubilize lipoproteins as they circulate in the
blood [50,51]. Both LPL and APOE polymorphisms have
been found to be significantly associated with increases
in LDL and decreases in HDL [52]. The functional con-
nection between the OASL gene (2’,5’-oligoadenylate
synthetase-like, also known as “thyroid hormone recep-
tor interactor”) and these phenotypes is unclear. How-
ever, nearby genes in linkage disequilibrium with the
lead SNP in OASL include HNF1A and c12orf43.
HNF1A is expressed in liver, kidney and endocrine pan-
creas and regulates a number of genes involved in lipo-
protein metabolism including apolipoproteins,
cholesterol synthesis enzymes and bile acid transporters
[53]. HNF1A also has allelic associations with type 2 dia-
betes [54], CRP [55-57] and coronary heart disease [58].
The findings for the lipids, in particular, were similar to
those obtained in previous genetic association studies on
general population. However the relationships between
inflammation (as presumptively measured by CRP) and
the traits associated with obesity and cardiovascular risk
are of particular interest. CRP was significantly, though
not always strongly, correlated with each of the other
traits at the phenotypic level and it also showed up in
the multivariate association findings.
The multivariate approach helps us to understand the
connections between variables. For example, for
rs2075650 on chromosome 19, the multivariate
approach suggested LDL, CRP, HDL and triglycerides
m i g h tb ea s s o c i a t e dw i t ht h i s particular SNP. Although
the effects on LDL, HDL and triglycerides are consistent
with what was expected (that is, the LDL effect is inver-
sely associated with the HDL effect, positively associated
with the triglycerides effect, and the HDL effect is inver-
sely associated with that on triglycerides), the effects on
CRP are contrary to expectation. The effect direction is
opposite to those for LDL and triglycerides, and the
same as that for HDL. This suggests that the alleles or
haplotype which have risk-increasing effects on lipids
have a potentially protective effect on CRP and (so far
as the effect on CRP is reflecting the degree of inflam-
mation) on the inflammatory process. The effect esti-
mates of LDL for rs2075650 obtained in our study were
similar to obtained by Aulchenko et al. [43]. The effect
of rs2075650 [G] on LDL was estimated as 0.160 ±
0.018 by Aulchenko et al. and 0.153 ± 0.020 in our ana-
lysis. The effect estimates of CRP for this SNP was not
available from previous study for comparison. In addi-
tion, it was interesting to observe that rs4429638 which
is in partial LD (r
2 = 0.4) with rs2075650 has allelic
effects in the opposite direction on LDL [52,59-61] and
CRP [55]. Similarly on chromosome 12, rs3213545
affects LDL and CRP (and GGT) but not HDL or
Figure 3 Q-Q plot of multivariate analysis. Black points
correspond to SNPs included in the analyses. The 45° line refers to
no significant association. The dotted line corresponds to p-value of
5×1 0
-8. “Excluded” line is where SNPs that were found in
significant regions (genes) in univariate analyses were removed.
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Page 6 of 9triglycerides. Again, the allelic effects on LDL and CRP
are in opposite directions. This shows the usefulness of
the multivariate approach to help understand the con-
nections between several trait-SNP associations, which
can then be modelled and evaluated in more detail.
Our study differs from previous investigations as it
examines a large number of correlated biochemical
traits, initially using unrelated individuals and following
up the findings in other members of the families. It con-
firms some published associations and identifies new
ones. As our cohort consisted of adolescents and adults,
results from adults, adolescents and combined (adults
and adolescents) cohorts were examined and compared.
Because of the larger number of adults studied, results
from adults were similar to the combined data. Results
from the adolescents were not notably different from
the combined data.
One main limitation of our approach is that only a
subset of the data (from unrelated subjects) can be used
for the initial multivariate analysis. Although it would
add power, it is too computationally intensive to use all
the available data (that is, taking account of the family
structure) in genome-wide multivariate analysis.
Although a subset of data was used, the method applied
in our study was very efficient and easy to perform. A
more specific limitation in our data is that the glucose
and insulin measurements were not made on fasting
blood samples. In adults, we made adjustments for the
time since the last meal but in adolescents we had to
r e l yo nt h ef a c tt h e yw e r es e e na tt h es a m et i m eo fd a y
and blood was taken around three hours after the
expected time of breakfast.
Another set of limitations is related to the use of bio-
markers of risk or, for CRP, of systemic inflammation. It
seems that some loci may affect HDL-C or triglycerides
without affecting cardiovascular risk [49], and it is possi-
ble that some loci might affect serum CRP without
affecting inflammation. Nevertheless the divergence
between allelic effects on risk factors deserves further
examination.
Conclusion
Our study demonstrated that it is useful to examine
multiple phenotypes jointly in order to better under-
stand the connections between them and to make the
distinction between common and unique genetic effects.
Our efficient approach (a combination of multivariate
and univariate analysis) was able to identify three possi-
ble loci that might affect multiple traits, and validated
17 loci that have previously been reported. It highlighted
anomalous effects on CRP, which is increasingly recog-
nised as a marker of cardiovascular risk as well as of
inflammation. Confirmation and extension of our find-
ings will require studies which measure multiple
phenotypes in each genotyped subject, and will benefit
from combination of data from multiple studies to
achieve sufficient power.
Additional material
Additional file 1: Additional tables and references. Additional Tables
S1-S4 and references cited in these tables. Table S1 gives a descriptive
statistics for males and females in the two genotyped cohorts. Table S2
gives the phenotypic correlations between each pair of age-corrected
traits separately for males and females in combined sample. Table S3
compares the multivariate and univariates results from our study with
published results. Table S4 gives a summary of borderline significant
associations from multivariate analysis.
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